Breathe Well Live Well
The Indian Express |
Risk for Asthma Treatment Failure Rises With Age
Medscape Age is a risk factor for treatment failure in adults who have mild to moderate asthma, according to a large, retrospective cohort study published online June 11 in the American Journal of Respiratory and Critical Care Medicine. Patients aged 30 years … Asthma treatment less effective in patients over 30 |
View full post on asthma – Google News
Zee News |
Aerobic Exercise Improved Some Asthma Symptoms
Medscape Aerobic exercise, in the form of twice-a-week treadmill workouts, improved bronchial hyperresponsiveness in adults with moderate or severe persistent asthma, according to a small study published online June 10 in Thorax. "These results suggest that … Aerobic exercise may cut asthma severity Exercise May Alleviate Severe Asthma Symptoms |
View full post on asthma – Google News
Medscape |
FDA Panel Backs Mepolizumab for Severe Eosinophilic Asthma
Medscape A typical characteristic of mild asthma is airway inflammation due to eosinophils, and this inflammation is closely associated with the risk for severe asthma exacerbations. Several products are approved for long-term maintenance treatment of asthma … FDA panel backs approval of GSK asthma drug in adults Asthma Drug Targeting IL-5 Wins Partial Backing From FDA Advisers UPDATE: Glaxo's (GSK) Severe Asthma Drug Mepolizumab Found Effective in … |
View full post on asthma – Google News
|
Another Look: Linking Hygiene, Asthma, and Allergies
Medscape Conversely, the absence of such exposures in early life may result in the expression of undesirable responses such as allergies and asthma. The theory has never been convincingly supported. In this prospective study, a comprehensive questionnaire was … |
View full post on asthma – Google News
|
Prescribed therapy
Medscape Conclusions Patients with high ICS-to-total-asthma-medication ratios presented fewer asthma-related outcomes. The low ICS-to-total-asthma-medication ratio calculated with EMRs data reflects insufficient prescribing of ICS relative to all asthma … |
View full post on asthma – Google News
Medical Xpress |
Soy Supplement Did Not Improve Asthma
Medscape A dietary supplement containing soy isoflavones did not improve lung function or clinical outcomes in patients with poorly controlled asthma in a multicenter, randomized, double-blind, placebo-controlled clinical trial published in the May 26 issue of … Soy Supplements Don't Help With Asthma Severity Soy supplements don't improve asthma Soy Supplements Won't Ease Asthma, Study Finds |
View full post on asthma – Google News
|
Peanut Allergy More Common in Children With Asthma
Medscape DENVER — Many children with asthma are also allergic to peanuts, but are unaware of it, according to results from a study presented here at the American Thoracic Society 2015 International Conference. "We wanted to get a sense of whether the peanut … |
View full post on asthma – Google News
|
Managing Severe Asthma in Adults: Lessons From the ERS/ATS Guidelines
Medscape Recent findings An updated definition of severe asthma is provided together with the evaluation steps necessary to reach a diagnosis of severe asthma. The importance of phenotyping is emphasized, and recommendations are provided for therapies … |
View full post on asthma – Google News
|
Abstract and Introduction
Medscape Rationale Asthma exacerbations are commonly precipitated by viral upper respiratory infections (URIs). Vitamin D insufficiency associates with susceptibility to URI in patients with asthma. Trials of vitamin D in adults with asthma with incidence of … |
View full post on asthma – Google News
Medscape |
Biologic-Based Asthma Treatment Gaining Momentum
Medscape DENVER — The monoclonal antibody dupilumab (Sanofi, Regeneron) improves lung function and reduces severe exacerbations in patients with asthma, according to results presented here at the American Thoracic Society 2015 International Conference … Regeneron speeds toward the FDA with its would-be asthma blockbuster Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in … Sanofi, Regeneron Announce Positive Phase 2 Data for Asthma Drug |
View full post on asthma – Google News